Uniform Biological Material Transfer Agreement (UBMTA) is a standard agreement developed by the National Institutes of Health (NIH) for the transfer of biological material between non-profit institutions. The agreement is designed to streamline the transfer process and reduce the administrative burden associated with transferring biological materials, such as cell lines and DNA samples.
The UBMTA is available to non-profit institutions that are registered with the NIH Office of Biotechnology Activities (OBA). It covers the transfer of biological materials for research purposes, including materials that are proprietary or confidential. The agreement is designed to protect the intellectual property rights of the provider of the biological material, while also allowing the recipient to use the material for their own research purposes.
The UBMTA includes provisions for the ownership and use of the biological material, as well as restrictions on the transfer of the material to third parties. It also includes provisions for the return or destruction of the biological material when it is no longer needed.
One of the benefits of using the UBMTA is that it provides a standardized process for the transfer of biological material. This can help to reduce the time and administrative burden associated with negotiating individual transfer agreements for each material transfer. It also provides a framework for resolving disputes that may arise during the transfer process.
In general, the UBMTA is a useful tool for non-profit institutions that are engaged in research involving biological materials. It provides a simple and easy-to-use framework for the transfer of these materials, and can help to reduce the administrative burden associated with the transfer process. If you are interested in learning more about the UBMTA or how it can be used in your research, you should contact the NIH Office of Biotechnology Activities for more information.